1. Dry eye disease: A review of anti-inflammatory therapies;Nguyen;Taiwan J Ophthalmol,2023
2. Chan YH, Sun CC. Efficacy and safety of topical cyclosproin 0.1% inmoderate-to-severe dry eye disease refractory to topical cyclosporin 0.05% regimen. Taiwan J Ophthalmol 2023;13:68-74.
3. Conjunctival inflammation and dry eye symptoms at day 100 post-transplantation do not predict risk for chronic graft-versus-host disease;Shah;Taiwan J Ophthalmol,2023
4. Clinical outcomes of pre-stripped, pre-stained, and pre-loaded Descemet's membrane endothelial keratoplasty (”P3 DMEK”);Juratli;Taiwan J Ophthalmol,2023
5. Unmasking of subclinical keratoconus with Descemet membrane endothelial keratoplasty in Fuchs endothelial dystrophy;Yung;Taiwan J Ophthalmol,2023